Related content

Albutropin: a growth hormone-albumin fusion with improved pharmacokinetics and pharmacodynamics in rats and monkeys

By Osborn B.L.   Sekut L.   Corcoran M.   Poortman C.   Sturm B.   Chen G.   Mather D.   Lin H.L.   Parry T.J.  

European Journal of Pharmacology, Vol. 456, Iss. 1, 2002-12 ,pp. : 149-158

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Single Rising Intravenous Doses (0.5 mg-10 mg) and Determination of Absolute Bioavailability of the Dipeptidyl Peptidase-4 Inhibitor Linagliptin (BI 1356) in Healthy Male Subjects

By Retlich Silke  

Clinical Pharmacokinetics, Vol. 49, Iss. 12, 2010-12 ,pp. : 829-840

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of PEGylated IFN-β 1a Following Subcutaneous Administration in Monkeys

By Mager Donald E.   Neuteboom Berend   Jusko William J.  

Pharmaceutical Research, Vol. 22, Iss. 1, 2005-01 ,pp. : 58-61

Springer Publishing Company

Access to resources Recommend Favorite

Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor

By He Kan  

European Journal of Drug Metabolism and Pharmacokinetics, Vol. 36, Iss. 3, 2011-09 ,pp. : 129-139

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate

By Stangier Joachim  

Clinical Pharmacokinetics, Vol. 47, Iss. 5, 2008-01 ,pp. : 285-295

Adis International

Access to resources Recommend Favorite